The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism (Q35291820)

7 August 2017

1 reference

title

The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism (English)

1 reference

7 August 2017

main subject

venous thromboembolism

1 reference

Paul Alexander Kyrle

1

1 reference

7 August 2017

Sabine Eichinger

series ordinal

2

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

published in

Vienna Clinical Weekly

1 reference

7 August 2017

volume

115

1 reference

7 August 2017

issue

13-14

1 reference

7 August 2017

page(s)

471-474

1 reference

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

7 August 2017

cites work

1 reference

12 December 2020

The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group

1 reference

12 December 2020

The risk of recurrent venous thromboembolism in patients with and without factor V Leiden

1 reference

12 December 2020

Recurrence of venous thromboembolism in patients with familial thrombophilia

1 reference

12 December 2020

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

12 December 2020

Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism

1 reference

12 December 2020

Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin Gene

1 reference

12 December 2020

Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism

1 reference

12 December 2020

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

1 reference

12 December 2020

The risk of recurrent venous thromboembolism

1 reference

12 December 2020

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

12 December 2020

Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism

1 reference

12 December 2020

Hemorrhagic complications of anticoagulant treatment

1 reference

12 December 2020

The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene

1 reference

12 December 2020

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

12 December 2020

The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor V Leiden and a First Spontaneous Venous Thromboembolism

1 reference

12 December 2020

Prothrombin fragment F1 2 is not predictive for recurrent venous thromboembolism

1 reference

12 December 2020

The risk of recurrent venous thromboembolism among patients with high factor IX levels

1 reference

12 December 2020

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis

1 reference

12 December 2020

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study

1 reference

12 December 2020

Levels of prothrombin fragment F1 2 in patients with hyperhomocysteinemia and a history of venous thromboembolism

1 reference

12 December 2020

High plasma levels of factor VIII and the risk of recurrent venous thromboembolism

1 reference

12 December 2020

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators

1 reference

12 December 2020

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03041030

1 reference

7 August 2017

1 reference